Coordinating CAR-T trials means managing tight timelines, cryogenic handling, staffing gaps, and chain-of-identity risks where even small missteps can delay care.
- Digital Isn't The Strategy: What Actually Drives Value In Clinical Supply Transformation
- Why Lean Clinical Teams Often Create Fragile Clinical Supply Chains
- The Clinical Supply Risk In Pharma's PE Boom
- Choosing The Right Logistics Team For Complex Clinical Trials
- Scaling Security And Speed In Last-Mile Cold Chain Delivery For Clinical Trials
- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead
- The Firefighting Era Of Clinical Supply Chain Is Over. Here's What Replaces It
- Navigating FDA Inspections: Practical Steps For Clinical Supply Leaders, Part 2
ON-DEMAND WEBINARS
Discover how flexible, site-focused monitoring strategies are transforming clinical trials by improving communication, enhancing compliance, and resolving challenges before they impact study success.
Gain a deeper understanding of current directives and metrics to equip your team with the knowledge necessary to navigate the evolving landscape of sustainability.
Choosing the right clinical packaging and supply chain partner to support APAC studies can vary significantly based upon which countries are involved and the types of services required.
Join patient-centric supply chain expert Marco Hogenboom for a discussion on how to accelerate the delivery of advanced therapies in an unpredictable environment through supply chain customization from clinical to commercialization.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![iStock-1002126898-graph-tablet-meeting-risks-planning]( "Critical Requirements In Sourcing Comparator Drugs")
Critical Requirements In Sourcing Comparator DrugsSourcing comparator drugs has become complex in the clinical supply chain. As a result, clinical trial sponsors and pharma companies are eager to identify opportunities to overcome these challenges.
-
![GettyImages-893884852 doctors tablet data]( "Study, Not Software: Aligning RTSM To The Protocol")
Study, Not Software: Aligning RTSM To The ProtocolHow can RTSM platforms improve your clinical trial and how do they integrate with your crucial trial systems?
-
![Pharma Manufacturing GettyImages-1135140594]( "Outsourcing Your Highly Potent Oncology Drug Product")
Outsourcing Your Highly Potent Oncology Drug ProductPrecision oncology treatments require specialized manufacturing and packaging, leading companies to outsource production. Assessing a CDMO’s highly potent processing capabilities is critical.
-
![GettyImages-2036497889-lab-computer-research]( "RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It Matters")
RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It MattersExplore why RTSM should be viewed as a system for managing change. Learn how platform-based reusability reduces UAT churn, preserves institutional memory, and stabilizes mid-study amendments.
-
![Medical-Research-laborratory-GettyImages-1354172439]( "Investigational Medicinal Products: Labeling Changes And Their Implications")
Investigational Medicinal Products: Labeling Changes And Their ImplicationsLearn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.
-
![GettyImages-1429005105-scientist-ipad-software-management]( "Choosing RTSM? Evaluate The Team Running It, Not Just The Software")
Choosing RTSM? Evaluate The Team Running It, Not Just The SoftwareHigh-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.
-
![small-mole-cdmo-GettyImages-1465073057]( "Clinical Development And Supply: Breaking Down Early Small Molecule Development")
Clinical Development And Supply: Breaking Down Early Small Molecule DevelopmentAdopt an integrated development strategy to streamline the path from early development to the clinic, ensuring timely clinical supply while reducing delays, risk, and inefficiencies.
-
![Laptop clinical trials iStock-653839742]( "What Are Decentralized Clinical Trials (DCTs)?")
What Are Decentralized Clinical Trials (DCTs)?Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
![GettyImages-1266357505-vaccine-development-lab]( "How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial Needs")
How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial NeedsWhen selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.
-
![genetic research, biotechnology, molecular biology, innovation, healthcare solutions-GettyImages-2234236209]( "Advantages Of Sourcing Biosimilars Vs. Branded Biologics In Clinical Trials")
Advantages Of Sourcing Biosimilars Vs. Branded Biologics In Clinical TrialsEvaluate biosimilar alternatives during clinical trial planning to reduce comparator drug costs and improve overall study efficiency without compromising trial integrity.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
